VNGOC: Welcome to Jallal Toufiq, the President of the International Narcotics Control Board (INCB), and Mark Colhoun, the INCB Secretary. International Association for Hospice and Palliative Care (IAHPC): With the USAID program cuts to vital health products, including ARVs in the lowest resource countries, we can expect an escalating pain burden and demand for essential …
Veterans Action Council
Informal NGO dialogue with UNODC Executive Director
UNODC ED: I am very pleased to be here despite how busy I am. This meeting is different every year – it is the voice of civil society and the people who have gone the difficult road to be the voice of people who can’t express themselves. We are going through difficult times for multilateralism …
Informal Civil Society Dialogue with World Health Organisation
Penny Hill, VNGOC. Good morning everyone, I will hand over to colleagues to introduce themselves. We have Deus and Delkushi today, as well as Anya Busha. Unfortunately Annette Verster is unable to join this morning but Anya will answer some of these questions. Question 1: Can you speak to the current process the WHO is …
Informal Civil Society Dialogue with OHCHR, UNAIDS & UNDP
Augusto, VNGOC. Thank you very much for being here today in the room and online. We have 18 questions so let’s start the process now. For ALL: Eurasian harm reduction association / Eurazijos žalos mažinimo asociacija. My question is about planned coordinated actions to get governmental commitments to decriminalize drug use and possession for personal …
Informal Civil Society Dialogue with the CND Chair
Informal Civil Society Dialogue with the CND Chair 21 March 2024 at 09AM – 10AM CET (C-CR-7 & via MS Teams) Penny Hill (Moderator, VNGOC): Welcome everyone Philbert Abaka Johnson, CND Chair: We cannot achieve optimal results unless everyone is involved in addressing the world drug problem. You play a valuable role, and at a …
Informal Dialogue with WHO
SSDP Australia: How is the World Health Organisation facilitating meaningful inclusion of people who use drugs in the design and implementation of policies and strategies around existing and emerging pharmacotherapies at the global level? WHO: The principle of involving affected groups in the development of guidance is strong. To develop WHO guidelines on managing health …